Aura Biosciences
AURA
106 hedge funds and large institutions have $319M invested in Aura Biosciences in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 13 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 25
15% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 13
2% more funds holding
Funds holding: 104 → 106 (+2)
1% more capital invested
Capital invested by funds: $317M → $319M (+$2.33M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
17.55% less ownership
Funds ownership: 100.69% → 83.14% (-18%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.7M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.14M |
| 3 |
BlackRock
New York
|
+$1.98M |
| 4 |
LCS
Levin Capital Strategies
New York
|
+$861K |
| 5 |
Walleye Capital
New York
|
+$440K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$2.71M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$928K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$407K |
| 4 |
HF
HRT Financial
New York
|
-$353K |
| 5 |
RCM
Regency Capital Management
Honolulu,
Hawaii
|
-$348K |
AURA Hedge Fund Activity: Q3 2025 in Review
106 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q3 2025, worth a combined $319M — up 0.73% from $317M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new AURA positions and 13 closed out — a net gain of 2 holders — while 35 added to existing stakes and 25 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.7M. The largest seller was Samsara BioCapital, cutting an estimated $2.71M.
- 106 institutional investors held Aura Biosciences (AURA) as of Q3 2025, up from 104 in Q2 2025.
- Funds reported $319M of Aura Biosciences stock for Q3 2025, up 0.73% quarter-over-quarter.
- 15 funds opened new Aura Biosciences positions in Q3 2025 and 13 closed out, a net change of +2 holders.
- The largest Aura Biosciences buyer in Q3 2025 was Vanguard Group, an estimated $2.7M added.
- The largest Aura Biosciences seller in Q3 2025 was Samsara BioCapital, an estimated $2.71M sold.
Based on aggregated 13F filings for Q3 2025.